{
    "nctId": "NCT00738998",
    "briefTitle": "Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors",
    "officialTitle": "Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 102,
    "primaryOutcomeMeasure": "Incidence, onset and severity of arthralgia during anastrozole treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients with early stage hormone receptor positive breast cancer who are at these 2 time points in their anastrozole treatment: 1) at the time period between two months prior or one month after beginning of their anastrozole treatment (Cohort 1); 2) patients within +/- 2 months of the beginning of the third year of anastrozole treatment (Cohort 2).\n2. Patients \\>= 18 years old.\n\nExclusion Criteria:\n\n1. Patients with metastatic disease.\n2. Patients who cannot complete the assessment tools.\n3. Patients without telephone access.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}